163 related articles for article (PubMed ID: 30589944)
41. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
[TBL] [Abstract][Full Text] [Related]
42. Anti-inflammatory activity of Wnt signaling in enteric nervous system: in vitro preliminary evidences in rat primary cultures.
Di Liddo R; Bertalot T; Schuster A; Schrenk S; Tasso A; Zanusso I; Conconi MT; Schäfer KH
J Neuroinflammation; 2015 Feb; 12():23. PubMed ID: 25644719
[TBL] [Abstract][Full Text] [Related]
43. Enteric neuronal density contributes to the severity of intestinal inflammation.
Margolis KG; Stevanovic K; Karamooz N; Li ZS; Ahuja A; D'Autréaux F; Saurman V; Chalazonitis A; Gershon MD
Gastroenterology; 2011 Aug; 141(2):588-98, 598.e1-2. PubMed ID: 21635893
[TBL] [Abstract][Full Text] [Related]
44. The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
Shannon K; Vanden Berghe P
Cell Tissue Res; 2018 Jul; 373(1):313-326. PubMed ID: 29936550
[TBL] [Abstract][Full Text] [Related]
45. Aggregation of alpha-synuclein in enteric neurons does not impact function in vitro.
Bindas AJ; Nichols KN; Roth NJ; Brady R; Koppes AN; Koppes RA
Sci Rep; 2022 Dec; 12(1):22211. PubMed ID: 36564445
[TBL] [Abstract][Full Text] [Related]
46. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats.
Soret R; Chevalier J; De Coppet P; Poupeau G; Derkinderen P; Segain JP; Neunlist M
Gastroenterology; 2010 May; 138(5):1772-82. PubMed ID: 20152836
[TBL] [Abstract][Full Text] [Related]
47. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease.
Chu Y; Mickiewicz AL; Kordower JH
Neurobiol Dis; 2011 Jan; 41(1):71-82. PubMed ID: 20816781
[TBL] [Abstract][Full Text] [Related]
48. Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons.
Bu J; Qiao X; He Y; Liu J
Life Sci; 2019 Aug; 231():116581. PubMed ID: 31220524
[TBL] [Abstract][Full Text] [Related]
49. Early inflammatory damage to intestinal neurons occurs via inducible nitric oxide synthase.
Venkataramana S; Lourenssen S; Miller KG; Blennerhassett MG
Neurobiol Dis; 2015 Mar; 75():40-52. PubMed ID: 25562655
[TBL] [Abstract][Full Text] [Related]
50. Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system.
Le Loupp AG; Bach-Ngohou K; Bourreille A; Boudin H; Rolli-Derkinderen M; Denis MG; Neunlist M; Masson D
BMC Gastroenterol; 2015 Sep; 15():112. PubMed ID: 26338799
[TBL] [Abstract][Full Text] [Related]
51. Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous system.
Rühl A; Hoppe S; Frey I; Daniel H; Schemann M
J Comp Neurol; 2005 Sep; 490(1):1-11. PubMed ID: 16041713
[TBL] [Abstract][Full Text] [Related]
52. Amyloid oligomerization of the Parkinson's disease related protein α-synuclein impacts on its curvature-membrane sensitivity.
Gallea JI; Ambroggio EE; Vilcaes AA; James NG; Jameson DM; Celej MS
J Neurochem; 2018 Nov; 147(4):541-556. PubMed ID: 30142705
[TBL] [Abstract][Full Text] [Related]
53. Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro.
Braidy N; Gai WP; Xu YH; Sachdev P; Guillemin GJ; Jiang XM; Ballard JW; Horan MP; Fang ZM; Chong BH; Chan DK
Neurotox Res; 2014 Feb; 25(2):170-82. PubMed ID: 24026637
[TBL] [Abstract][Full Text] [Related]
54. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
[TBL] [Abstract][Full Text] [Related]
55. Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
Liu Y; Sun JD; Song LK; Li J; Chu SF; Yuan YH; Chen NH
Behav Brain Res; 2015 Nov; 294():149-61. PubMed ID: 26239001
[TBL] [Abstract][Full Text] [Related]
56. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
Noorian AR; Rha J; Annerino DM; Bernhard D; Taylor GM; Greene JG
Neurobiol Dis; 2012 Oct; 48(1):9-19. PubMed ID: 22722052
[TBL] [Abstract][Full Text] [Related]
57.
Brun P; Qesari M; Marconi PC; Kotsafti A; Porzionato A; Macchi V; Schwendener RA; Scarpa M; Giron MC; Palù G; Calistri A; Castagliuolo I
Front Cell Infect Microbiol; 2018; 8():74. PubMed ID: 29600197
[No Abstract] [Full Text] [Related]
58. Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.
Beatman EL; Massey A; Shives KD; Burrack KS; Chamanian M; Morrison TE; Beckham JD
J Virol; 2015 Dec; 90(6):2767-82. PubMed ID: 26719256
[TBL] [Abstract][Full Text] [Related]
59. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
60. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
